Congress must deal with a growing number of issues that new technological developments are forcing on the nation. I deliberately write forcing because the way technology works, no one asks the nation or its elected representatives if we need or want a given new technology. Any investor or engineer, these days more often a startup group or a tech corporation, can make the nation adapt to whatever they concoct.
For instance, a small group of young hotshot engineers is perfecting deep fake, a technology that enables one to make a video that will seem to be a very authentic presentation by a well-known politician, only it is completely made up. To consider the implications of this new gift to mankind, imagine that a day before the election, a candidate states that she has changed her mind and now favors something that will completely antagonize her base. By the time denials are issued and the truth comes out, the election may well be lost.
All of this does not point to the need for some licensing board to which technologists will have to apply before they can proceed but to a growing and urgent need for the nation to have the capacity to learn about new technological developments as early as possible, and prepare to deal with the consequences. And, possibly, in some rare cases well need to impose some restrictions on these developments.
Individual members of Congress and their staffs often do not have the resources, time or sufficient technical backgrounds to carry out such assessments. Hence the merit of recent moves to reestablish an Office of Technology Assessment (OTA) to play a major role in preparing technological assessments for Congress.
Last April Rep. Tim RyanTimothy (Tim) RyanOffice of Technology Assessment: It's time for a second coming Key moments in the 2020 Democratic presidential race so far GM among partners planning .3B battery plant in Ohio MORE (D-Ohio) included funding for OTA in a 2020 spending bill. But when the matter was discussed during a hearing of the House Committee on Science, Space and Technology in December, only a few members seemed to favor a full revival of the OTA.
The value of the defunct OTA is captured in an op-ed by Celia Wexler, the senior Washington representative at the Center for Science and Democracy. Wexler wrote:
The information they provided was used to make smart and applicable policy decisions. A 1984 study questioning the reliability of polygraph tests led Congress to enact limits on their use by employers. Another report from 1994 helped lawmakers assess the Social Security Administrations computer procurement plan, and ended up saving the government $368 million. OTA reports in 1987 and 1990, which concluded that Pap smears and mammograms for older women could save thousands of lives, were instrumental in extending Medicare reimbursement for these tests.
In 1972, Congress created the Office of Technology Assessment (OTA) to counsel senators and members of the House of Representatives on topics related to science and technology. Its ambitious goal was to give Congress technical expertise equal to that available to the executive branch through its many departments and agencies. The OTA board included representatives of both political parties and houses of Congress.
For over 20 years it produced approximately 750 reports dealing with issues raised by new technologies.
Congress defunded the OTA in 1995, keeping a promise that Rep. Newt GingrichNewton (Newt) Leroy GingrichMORE (R-Ga.) made during the successful Republican election campaign in 1994. Rep. Robert S. Walker (R-Pa.), who chaired the House Science Committee, disapproved of the OTA, argued that the pieces of legislation its reports were meant to inform often had to proceed without them due to the amount of time it took the OTA to produce a report.
The director of the agency acknowledged that it did not always finish reports in time to inform legislation. But he noted that agency researchers had testified about their work in progress at hearings and prepared less lengthy interim reports, when requested.
No single reason was given for the closing of the OTA. But some Republican lawmakers came to view it as duplicative, wasteful and biased against their party.
Another factor in the demise of OTA were, oddly, its neutrality. A former head of the OTA, Dr. John H. Gibbons, put it this way: If you belong to everyone, you belong to no one.
Another complaint was the dearth of public participation. Jathan Sadowski of the Consortium for Science, Policy & Outcomes at Arizona State University explained that [i]t did not adequately collect and examine the perspectives of a wider citizenryby, say, changing up their advisory panels or through methods like opinion polling and consensus conferences.
A major reason why the OTA must be revived is the accelerating pace of technological innovation, including in countries such as China. To illustrate, we need to assess the effect of AI (whether advanced in the U.S., China, Israel or elsewhere) on the destruction of jobs; the safety of driverless autos; the morality of the use of CRISPR for genetic engineering; facial recognition as a public safety tool; the impact of social media on democracy and society; and much more.
There seems to be ample work for at least one OTA. But it may well need to draw on the help of other organizations, such as the National Academy of Sciences, the NSF and DARPA.
Amitai Etzioni is a university professor and professor of international affairs at The George Washington University. Click here to watch a recent, four-minute video Political and Social Life after Trump. His latest book, Reclaiming Patriotism, was published by University of Virginia Press in 2019 and is available for download without charge.
View original post here:
Office of Technology Assessment: It's time for a second coming | TheHill - The Hill
- genetic engineering summary | Britannica - September 13th, 2024
- The great gene editing debate: can it be safe and ethical? - BBC.com - September 13th, 2024
- Anti-biotechnology campaigners embrace classic crops, are suspicious of hybrid varieties and claim genetic modification violates nature. Heres a... - September 13th, 2024
- Will IL-11 Control Extend Human Life One Day? Early Results are Tantalizing - Securities.io - September 13th, 2024
- Viewpoint: As New Zealand edges toward relaxing its ban on gene edited foods, experts weigh in - Genetic Literacy Project - September 13th, 2024
- Farmers in Brazil and Argentina ramp up growing of genetically-modified drought tolerant wheat that can grow in subtropical regions - Genetic Literacy... - September 13th, 2024
- Scientist explains why we'll never have a real Jurassic Park - and people are crestfallen - indy100 - September 13th, 2024
- Genetic engineering techniques - Wikipedia - January 9th, 2024
- 20.3: Genetic Engineering - Biology LibreTexts - January 9th, 2024
- Genetic engineering - DNA Modification, Cloning, Gene Splicing - December 13th, 2023
- Global Gene Editing Market Poised for Significant Growth, Projected to Reach $14.28 Billion by 2027 - EIN News - December 13th, 2023
- Principles of Genetic Engineering - PMC - National Center for ... - May 17th, 2023
- Quitting: A Life Strategy: The Myth of Perseveranceand How the New Science of Giving Up Can Set You Free - Next Big Idea Club Magazine - May 17th, 2023
- 18 Human Genetic Engineering - Clemson University - March 29th, 2023
- Pros and Cons of Genetic Engineering - Benefits and Risks - March 29th, 2023
- How artificial skin is made and its uses, from treating burns to skin cancer - South China Morning Post - March 29th, 2023
- Genetic Engineering - Meaning, Applications, Advantages and Challenges ... - March 13th, 2023
- Revolutionary Specialty Enzymes Transform Industries, Projected to Reach $2.2 Billion by 2031 - Billion-Dollar - EIN News - March 5th, 2023
- Explained: What is genome editing technology and how is it different from GM technology? - The Indian Express - April 2nd, 2022
- Scribe Therapeutics to Participate in Upcoming Goldman Sachs The New Guard: Privates Leading the Disruption in Healthcare Investor Conference - Yahoo... - April 2nd, 2022
- San Antonio Zoo In Discussions on Woolly Mammoth Project - iHeart - April 2nd, 2022
- Xenotransplantation trials will require adjusting expectations, experts say - STAT - April 2nd, 2022
- 5 Interesting Startup Deals You May Have Missed In March: Restoring The Woolly Mammoth, Faux Seafood And Lots Of Bees - Crunchbase News - April 2nd, 2022
- Synlogic to Present Data on Phenylketonuria and Homocystinuria Programs at the Society for ... - KULR-TV - April 2nd, 2022
- The Bay Area food tech industry is creating more than vegan burgers. Heres whats next - San Francisco Chronicle - April 2nd, 2022
- Student Startup Teams to Compete For $110000 Cash Prize Pool in U of A's Heartland Challenge - University of Arkansas Newswire - April 2nd, 2022
- Should we test for differences in allergen content between varieties of crops and animal species? - Open Access Government - April 2nd, 2022
- Genetic Engineering - Courses, Subjects, Eligibility ... - December 22nd, 2021
- Scientists Used CRISPR Gene Editing to Choose the Sex of Mouse Pups - Singularity Hub - December 22nd, 2021
- Report calls for broad public deliberation on releasing gene-edited species in the wild - EurekAlert - December 22nd, 2021
- RNA and DNA Extraction Kit Market Study | Know the Post-Pandemic Scenario of the Industry - BioSpace - December 22nd, 2021
- Opinion: Allow Golden Rice to save lives - pnas.org - December 22nd, 2021
- It's time for an alliance of democracies | TheHill - The Hill - December 22nd, 2021
- Aridis Pharmaceuticals Announces a Pan-Coronavirus Monoclonal Antibody Cocktail That Retains Effectiveness Against the Omicron variant, other COVID-19... - December 22nd, 2021
- 2021: when the link between the climate and biodiversity crises became clear - The Guardian - December 22nd, 2021
- Wuhan lab leak now the most likely cause of Covid pandemic and the truth WILL come out, experts tell MPs... - The US Sun - December 22nd, 2021
- Biotech ETFs That Outperformed Last Week - Yahoo Finance - December 22nd, 2021
- Human genetic enhancement - Wikipedia - October 5th, 2021
- Viewpoint: Part 1 Opposition stirred by anti-GMO advocacy group propaganda fading in the developing world, as more countries embrace crop... - October 5th, 2021
- Amyris Partners with Inscripta to Enhance Development of Sustainable Ingredients Using the Onyx Genome Engineering Platform - WWNY - October 5th, 2021
- Kingdom Supercultures raises $25m to expand Non GMO suite of microbes to unlock new flavors, textures, and functionalities in food & beverage -... - October 5th, 2021
- Fact check: Genetically engineering your salad with the COVID-19 vaccines? We're not there yet. - USA TODAY - October 5th, 2021
- Making the Transition from an Academic to a Biobusiness Entrepreneur - Genetic Engineering & Biotechnology News - October 5th, 2021
- Is The New York Times Finally 'Learning To Love GMOS'? - American Council on Science and Health - October 5th, 2021
- Gene editing, joke theft and manifesting - The Week UK - October 5th, 2021
- Opinion: Saving lives through real social justice - Agri-Pulse - October 5th, 2021
- Science, business and the humanities: CP Snow's 'Two Cultures' sixty years on - TheArticle - October 5th, 2021
- Probiotic Yeast Engineered To Produce Beta-Carotene - Technology Networks - April 17th, 2021
- In the US, Imminent Release of Genetically Modified Mosquitoes To Fight Dengue - The Wire Science - April 17th, 2021
- CRISPRoff: A New Addition to the CRISPR Toolbox - Technology Networks - April 17th, 2021
- A Massive New Gene Editing Project Is Out to Crush Alzheimer's - Singularity Hub - April 17th, 2021
- Grammar of the Genome: Reading the Influence of DNA on Disease - Baylor University - April 17th, 2021
- We cannot let China set the standards for 21st century technologies | TheHill - The Hill - April 17th, 2021
- First GMO Mosquitoes to Be Released in the Florida Keys - Singularity Hub - April 17th, 2021
- Novavax to Participate in University of Oxford Com-COV2 Study Comparing Mixed COVID-19 Vaccine Combinations - BioSpace - April 17th, 2021
- AmunBio and NorthShore University to Advance Cancer Immunotherapy with Engineered Oncolytic Viruses - OncoZine - April 17th, 2021
- StrideBio Announces a Multi-technology License and Master SRA with Duke University to Advance Next-generation Gene Therapies - BioSpace - April 17th, 2021
- ThermoGenesis : The History of Cell and Gene Therapy - marketscreener.com - April 17th, 2021
- EU's refusal to permit GMO crops led to millions of tonnes of additional CO2, scientists reveal - Alliance for Science - Alliance for Science - February 14th, 2021
- New species of fly named after Singanallur Tank - The Hindu - February 14th, 2021
- Son of Monarchs Pays Homage to the Beauty of Migration - Sierra Magazine - February 14th, 2021
- Podcast: TIME's 2020 Kid of the Year, Gitanjali Rao - All Together - Society of Women Engineers - February 14th, 2021
- Geoengineering: What could possibly go wrong? Elizabeth Kolbert's take, in her new book - Bulletin of the Atomic Scientists - February 14th, 2021
- An Introduction to PCR - Technology Networks - February 14th, 2021
- Science Talk - Evolution, cancer and coronavirus how biology's 'Theory of Everything' is key to fighting cancer and global pandemics - The Institute... - February 14th, 2021
- 22nd Century Group and KeyGene Launch Advanced Cannabis Technology Platform for Accelerated Development of New Varieties of Hemp/Cannabis Plants with... - February 14th, 2021
- Aleph Farms and The Technion Reveal World's First Cultivated Ribeye Steak - PRNewswire - February 9th, 2021
- Researchers create rice that captures more CO2 with 30 percent more yield - FoodIngredientsFirst - February 9th, 2021
- Interview: Elizabeth Kolbert on why well never stop messing with nature - Grist - February 9th, 2021
- Is Biotechnology the Answer to a More Sustainable Beauty Industry? - Fashionista - February 9th, 2021
- New Jersey arts and entertainment news, features, and event previews. - New Jersey Stage - February 9th, 2021
- CollPlant Announces Development and Global Commercialization Agreement with Allergan Aesthetics, an AbbVie company, for rhCollagen in Dermal and Soft... - February 9th, 2021
- Taysha Gene Therapies Announces Collaborations to Advance Next-Generation Mini-Gene Payloads for AAV Gene Therapies for the Treatment of Genetic... - February 9th, 2021
- A new tool to investigate bacteria behind hospital infections - MIT News - February 9th, 2021
- Outlook on the CRISPR Gene Editing Global Market to 2030 - Analysis and Forecasts - GlobeNewswire - February 9th, 2021
- Novavax Announces Start of Rolling Review by Multiple Regulatory Authorities for COVID-19 Vaccine Authorization - GlobeNewswire - February 9th, 2021
- Global Lab-On-A-Chip Market Industry Perspective, Comprehensive Analysis, and Forecast 2027||Players-Perkin Elmer Corporation, IDEX, Thermo Fisher... - February 9th, 2021
- Freeline Presents Data on its Gaucher Disease and Fabry Disease AAV-Based Gene Therapies at the 17th Annual WORLDSymposium - PharmiWeb.com - February 9th, 2021
- Global Bacterial and Plasmid Vectors Market Report 2020: Market is Expected to Recover and Reach $0520 Million in 2023 at a CAGR of 15.48% - Forecast... - January 12th, 2021
- mRNA Technology Gave Us the First COVID-19 Vaccines. It Could Also Upend the Drug Industry - TIME - January 12th, 2021